These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12472362)

  • 21. Use of mycophenolate mofetil in erythema nodosum.
    Boyd AS
    J Am Acad Dermatol; 2002 Dec; 47(6):968-9. PubMed ID: 12451393
    [No Abstract]   [Full Text] [Related]  

  • 22. Mycophenolate mofetil and erythromycin for bullous lupus erythematosus of childhood.
    Pehr K
    J Cutan Med Surg; 2012; 16(1):50-3. PubMed ID: 22417996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study.
    Keyes E; Jobanputra A; Feng R; Grinnell M; Vazquez T; Diaz D; Werth VP
    J Am Acad Dermatol; 2022 Aug; 87(2):447-448. PubMed ID: 34537250
    [No Abstract]   [Full Text] [Related]  

  • 24. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
    Sakamoto T; Hashimoto T; Furukawa F
    Eur J Dermatol; 2002; 12(5):485-7. PubMed ID: 12370142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cigarette smoking is associated with decreased long-term treatment cessation of mycophenolate mofetil and methotrexate in cutaneous lupus erythematosus.
    Chen HW; Sprow G; Feng R; Werth VP; Chong BF
    Lupus; 2023 Aug; 32(9):1134-1137. PubMed ID: 37328162
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of mycophenolate mofetil on cutaneous lupus erythematosus in (NZB × NZW) F1 mice.
    Lee YF; Cheng CC; Lan JL; Hsieh TY; Lin NN; Lin HY; Chiu YT
    J Chin Med Assoc; 2013 Nov; 76(11):615-23. PubMed ID: 23968808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil in epidermolysis bullosa acquisita.
    Kowalzick L; Suckow S; Ziegler H; Waldmann T; Pönnighaus JM; Gläser V
    Dermatology; 2003; 207(3):332-4. PubMed ID: 14571084
    [No Abstract]   [Full Text] [Related]  

  • 28. Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
    Grundmann-Kollmann M; Podda M; Ochsendorf F; Boehncke WH; Kaufmann R; Zollner TM
    Arch Dermatol; 2001 Jul; 137(7):870-3. PubMed ID: 11453805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The different faces of cutaneous lupus erythematosus.
    Renner R; Sticherling M
    G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl.
    Tincopa M; Puttgen KB; Sule S; Cohen BA; Gerstenblith MR
    Pediatr Dermatol; 2010; 27(4):373-6. PubMed ID: 20653856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mepacrine in Recalcitrant Cutaneous Lupus Erythematosus: Old-fashioned or Still Useful?
    Benoit S; Goebeler M
    Acta Derm Venereol; 2015 May; 95(5):596-9. PubMed ID: 25474442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous lupus mucinosis successfully treated with systemic corticosteroid and systemic tacrolimus combination therapy.
    Sugiura K; Tanahashi K; Muro Y; Akiyama M
    J Am Acad Dermatol; 2013 Oct; 69(4):e200-2. PubMed ID: 24034403
    [No Abstract]   [Full Text] [Related]  

  • 33. Mycophenolate mofetil therapy in a child with Churg-Strauss syndrome.
    Demircin G; Baysun S; Bülbül M; Erdoğan O; Oner A
    Pediatr Int; 2010 Jun; 52(3):e164-6. PubMed ID: 20723119
    [No Abstract]   [Full Text] [Related]  

  • 34. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythema Elevatum Diutinum Treated With Mycophenolate Mofetil.
    Bevans SL; Keeley JM; Sami N
    J Clin Rheumatol; 2019 Sep; 25(6):e93-e94. PubMed ID: 29509562
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mycophenolate mofetil for induction of remission in Wegener's granulomatosis].
    Kötter I
    Z Rheumatol; 2007 Sep; 66(5):441-3. PubMed ID: 17717676
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic involvement in TREX1-associated familial chilblain lupus.
    Günther C; Hillebrand M; Brunk J; Lee-Kirsch MA
    J Am Acad Dermatol; 2013 Oct; 69(4):e179-81. PubMed ID: 24034389
    [No Abstract]   [Full Text] [Related]  

  • 39. Mycophenolate mofetil for Crohn's disease?
    Lowry PW; Sandborn WJ; Lipsky JJ
    Lancet; 1999 Jul; 354(9172):3-4. PubMed ID: 10406354
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.